Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 257
- Libros 4
- Capítulos de libro 3
- Congresos 91
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 1
- Tesis dirigidas 9
- Patentes o licencias de software 0
135 POSTER Development of a high-sensitive antibody-based protein array system that quantitatively detects serum Fatty Acid Synthase (sFASN) in breast cancer: correlation with …
- JA Menendez
- A Vazquez-Martin
- R Colomer
Ejc Supplements (p. 44-44) - 1/1/2006
- iMarina
3D Assessment of Lymph Nodes vs. RECIST 1.1
- Steger, Sebastian
- Franco, Fabio
- Sverzellati, Nicola
- Chiari, Gianfranco
- Colomer, Ramon;
Academic Radiology (p. 391-394) - 1/3/2011
10.1016/j.acra.2010.11.010 Ver en origen
- ISSN 10766332
554 POSTER The mTOR effector p70 S6 kinase 1 (S6K1): a specific biomarker for the biological effects of the dual HER1/HER2 kinase inhibitor Lapatinib (GW572016) in HER2 …
- A Vazquez-Martin
- R Colomer
- JA Menendez
Ejc Supplements (p. 168-168) - 1/1/2006
- iMarina
?-6 polyunsaturated fatty acid ?-linolenic acid (18: 3n-6) is a selective estrogen-response modulator in human breast cancer cells: ?-linolenic acid antagonizes estrogen …
- Javier A Menendez
- Ramon Colomer
- Ruth Lupu
International Journal Of Cancer (p. 949-954) - 1/1/2004
- ISSN 00207136
- iMarina
A FREQUENT TYROSINASE GENE MUTATION ASSOCIATED WITH TYPE I-A (TYROSINASE-NEGATIVE) OCULOCUTANEOUS ALBINISM IN PUERTO-RICO
American Journal Of Human Genetics (p. 17-23) - 1/1/1993
- ISSN 00029297
- iMarina
A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms
- Maria J Bueno
- Ramon Colomer
Ebiomedicine (p. 778-779) - 1/8/2015
10.1016/j.ebiom.2015.08.023 Ver en origen
- ISSN 23523964
- iMarina
- iMarina
A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer
- Pacheco-Barcia, V.
- Mondéjar Solís, R.
- France, T.
- Asselah, J.
- Donnay, O.
- Zogopoulos, G.
- Bouganim, N.
- Guo, K.
- Rogado, J.
- Martin, E.
- Alcindor, T.
- Colomer, R.
Pancreas (p. E45-E47) - 1/5/2019
Editor: Lippincott Williams and Wilkins
10.1097/mpa.0000000000001294 Ver en origen
- ISSN 08853177
- ISSN/ISBN 1536-4828
A cytotoxic ribonuclease reduces the expression level of P-glycoprotein in multidrug-resistant cell lines
- Castro, Jessica
- Ribo, Marc
- Puig, Teresa
- Colomer, Ramon
- Vilanova, Maria
- Benito, Antoni;
Investigational New Drugs (p. 880-888) - 1/6/2012
10.1007/s10637-011-9636-2 Ver en origen
- ISSN 15730646
A new multidisciplinary Spanish Working Group on Cancer Biomarkers: presentation and aims
- Colomer, R.
- Garrido, P.
- De Álava, E.
- Alfonso, P.G.
- Palacios, J.
- Ariza, A.
Clinical & Translational Oncology (p. 323-324) - 1/5/2012
10.1007/s12094-012-0803-5 Ver en origen
- ISSN 1699048X
- ISSN/ISBN 1699-048X
A new role for circulating T follicular helper cells in humoral response to anti-PD-1 therapy
- Sanchez-Alonso, Santiago
- Setti-Jerez, Giulia
- Arroyo, Montserrat
- Hernandez, Tathiana
- Inmaculada Martos, Ma
- Miguel Sanchez-Torres, Jose
- Colomer, Ramon
- Ramiro, Almudena R.
- Alfranca, Arantzazu;
Journal For Immunotherapy Of Cancer - 7/9/2020
10.1136/jitc-2020-001187 Ver en origen
- ISSN 20511426
Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study
- J Albanell
- E Ciruelos
- R Colomer
- J De la Haba
- M Martin
- De Salas-Cansado
- B Munoz-Molina
- C Tournier
- P Thuresson
- W Schleich
1/1/2015
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
Medicina de precisión en oncología: Éxitos y perspectivas bioéticas
- Ramón Colomer Bosch
Bioética Y Cáncer (p. 17-26) - 1/1/2020
- iMarina
COST-UTILITY ANALYSIS OF NEOADJUVANT CHEMOTHERAPY WITH PERTUZUMAB, TRASTUZUMAB AND DOCETAXEL IN PATIENTS WITH HER2+BREAST CANCER IN SPAINCO ST-UTILITY ANALYSIS OF NEOADJUVANT CHEMOTHERAPY WITH PERTUZUMAB, TRASTUZUMAB AND DOCETAXEL IN PATIENTS WITH HER2+BREAST CANCER IN SPAIN
- Colomer, R.
- Ciruelos, E.
- De la Haba, J.
- Martin, M.
- De Salas-Cansado, M.
- Munoz-Molina, B.
- Albanell, J.;
Value In Health (p. A740-A740) - 1/1/2016
10.1016/j.jval.2016.09.2249 Ver en origen
- ISSN 10983015
Circulating angiogenic growth factors as predictive factors in metastatic breast cancer treated with letrozole.
- Alba E
- Gonzalez F
- Llombart A
- Ramos M
- Mayordomo J
- Fernandez R
- Tusquets I
- Barnadas A
- Gil M
- Carabantes F
- Baena J
- Ruiz M
- Palomero M
- Vera R
- Munoz M
- Constenla M
- Rifa J
- Ojeda B
- Calvo L
- Lloveras B
- Colomer R
Breast Cancer Research And Treatment (p. 244-244) - 1/1/2001
- ISSN 01676806
- iMarina
Circulating erbB-2 and resistance to chemotherapy in advanced breast cancer.
- R Colomer
- S Montero
- A Liuch
- B Ojeda
- A Barnadas
- A Casado
- B Massuti
- B Lloveras
- H Cortes-Funes
Clinical Cancer Research (p. 3772S-3772S) - 1/1/1999
- ISSN 15573265
- iMarina
Correlation between HER2/neu overexpression/amplification and clinicopathologic parameters in advanced gastric cancer (AGC) patients (pts): A prospective study.
- C Gravalos
- A Marquez
- R Colomer
- R Garcia-Carbonero
- J Sastre
- F Rivera
- A Saenz-Cusi
- A Velasco
- C Guzman
- A Jimeno
Journal Of Clinical Oncology (p. 467-200S) - 1/1/2006
- ISSN 0732183X
- iMarina
Cost-effectiveness analysis of adding neoadjuvant chemotherapy with pertuzumab, in patients with HER2+breast cancer in Spain
- Abanell, J.
- Ciruelos, E.
- De la Haba, J.
- Martin, M.
- Munoz-Molina, B.
- De Salas-Cansado, M.
- Colomer, R.;
Cancer Research - 1/1/2017
10.1158/1538-7445.sabcs16-p3-12-02 Ver en origen
- ISSN 00085472
Could a systemic inflammation response index (SIRI) predict overall survival (OS) in metastatic pancreatic cancer (PC)?
- Pacheco-Barcia, V.
- Donnay, O.
- Mondejar, R.
- Rogado, J.
- Fenor de la Maza, M. D.
- Colomer, R.;
Annals Of Oncology - 1/1/2017
- ISSN 09237534
- iMarina
De novo designed cyclic decapeptides with anticancer activity
- Feliu, L.
- Oliveras, G.
- Diaz-Cirac, A.
- Cufi, S.
- Roses, C.
- Colomer, R.
- Bardaji, E.
- Planas, M.
- Puig, T.;
Journal Of Peptide Science (p. 117-117) - 1/1/2010
- ISSN 10752617
- iMarina
Determining the clinical significance of the improvement in health-related quality of life (HRQoL) measures in oncology patients
- Cassinello, J
- Carulla, J
- Valentin, V
- Rodriguez, C A
- Gascon, P
- Garcia-Mata, J
- Colomer, R
- Baro, E
- Gasquet, J A
Journal Of Clinical Oncology - 1/1/2008
10.1200/jco.2008.26.15_suppl.20622 Ver en origen
- ISSN 0732183X
Development of a high-sensitive antibody-based protein array system that quantitatively detects serum Fatty Acid Synthase (sFASN) in breast cancer: correlation with Her-2/neu (erbB-2) expression and trastuzumab efficacy
- Menendez, J. A.
- Vazquez-Martin, A.
- Colomer, R.;
European Journal Of Cancer, Supplement (p. 44-44) - 1/1/2006
10.1016/s1359-6349(06)70141-0 Ver en origen
- ISSN 13596349
Differential impact of single agent erlotinib in patients (P) with advanced or metastatic NSCLC untreated or pretreated with chemotherapy: Univariate and multivariate analysis
- Felipe Cardenal
- Hernan Cortes
- Ramon Colomer
- Pilar Garrido
- Amalia Velasco
- Cinta Pallares
- Alfonso Gurpide
- Manuel Cobo
- M Amador
- Bartomeu Massuti
Annals Of Oncology (p. 216-216) - 1/1/2006
- ISSN 09237534
- iMarina
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id